Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody

• 收藏
• 分享

专利权人:

Jill P. Smith

发明人:

Jill P. Smith

申请号：

US14474284

公开号：

US09562095B2

申请日:

2014.09.01

申请国别(地区):

US

年份:

2017

代理人:

摘要：

Human pancreatic cancer cells possess a distinct plasma membrane CCK receptor variant that can be differentiated from the classic CCK-B receptor with selective monoclonal antibodies. Use of this receptor may be helpful in early detection or treatment of patients with pancreatic cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/